Phase 2 Readout

ANTX: Phase2_Topline: AN2 Therapeutics Initiates Phase 2 Trial Of leucyl-tRNA Synthetase (LeuRS) Mycobacterium Abscessus, With Topline Data Planned For Late 2027

Name: Phase2_Topline: AN2 Therapeutics Initiates Phase 2 Trial Of leucyl-tRNA Synthetase (LeuRS) Mycobacterium Abscessus, With Topline Data Planned For Late 2027
Start: 2027-12-31
End: 2027-12-31

December 31, 2027. BioSniper AI can trace the company-impact path without requiring you to write the research question.

Event date: December 31, 2027
Company: AN2 Therapeutics, Inc. (ANTX)

BioSniper AIPage evidence connected

Prepared research question

What could this event change, and which evidence should be watched next?

Run cited research

Traceable citations · Unknowns marked

Phase 2 Readout~quarter

Phase2_Topline: AN2 Therapeutics Initiates Phase 2 Trial Of leucyl-tRNA Synthetase (LeuRS) Mycobacterium Abscessus, With Topline Data Planned For Late 2027

December 31, 2027

ANTX overview →

Company: AN2 Therapeutics, Inc. (ANTX)